Gould Capital’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.41K | Hold |
70
| – | – | ﹤0.01% | 172 |
|
|
2025
Q1 | $2.38K | Hold |
70
| – | – | ﹤0.01% | 176 |
|
|
2024
Q4 | $2.76K | Sell |
70
-35
| -33% | -$1.38K | ﹤0.01% | 172 |
|
|
2024
Q3 | $4.93K | Hold |
105
| – | – | ﹤0.01% | 167 |
|
|
2024
Q2 | $5.67K | Hold |
105
| – | – | ﹤0.01% | 162 |
|
|
2024
Q1 | $7.16K | Hold |
105
| – | – | 0.01% | 156 |
|
|
2023
Q4 | $6.57K | Sell |
105
-5
| -5% | -$313 | ﹤0.01% | 162 |
|
|
2023
Q3 | $4.67K | Hold |
110
| – | – | ﹤0.01% | 163 |
|
|
2023
Q2 | $6.18K | Hold |
110
| – | – | ﹤0.01% | 160 |
|
|
2023
Q1 | $4.98K | Buy |
110
+20
| +22% | +$905 | ﹤0.01% | 169 |
|
|
2022
Q4 | $3.66K | Hold |
90
| – | – | ﹤0.01% | 176 |
|
|
2022
Q3 | $6K | Hold |
90
| – | – | 0.01% | 155 |
|
|
2022
Q2 | $5K | Hold |
90
| – | – | ﹤0.01% | 163 |
|
|
2022
Q1 | $6K | Hold |
90
| – | – | ﹤0.01% | 159 |
|
|
2021
Q4 | $7K | Buy |
+90
| New | +$7K | ﹤0.01% | 168 |
|